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Abstract 
Background: Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age, 
and oocyte developmental competence is altered in patients with PCOS. In recent years microRNAs (miRNAs) have 
emerged as important regulators of gene expression, the aim of the study was to study miRNAs expression patterns 
of cumulus cells from PCOS patients.
Methods: The study included 20 patients undergoing in vitro fertilization (IVF) and intra-cytoplasmic sperm injec-
tion (ICSI): 10 diagnosed with PCOS and 10 matching controls. We used deep sequencing technology to identify the 
miRNAs differentially expressed in the cumulus cells of PCOS.
Results: There were 17 differentially expressed miRNAs in PCOS cumulus cells, including 10 miRNAs increase and 
7 miRNAs decrease. These miRNAs were predicted to target a large set of genes with different functions, including 
Wnt- and MAPK- signaling pathways, oocyte meiosis, progesterone-mediated oocyte maturation and cell cycle. Unsu-
pervised hierarchical clustering analysis demonstrated that there was a specific miRNAs expression pattern in PCOS 
cumulus cells.
Conclusion: We found that the miRNAs expression profile was different in cumulus cells isolated from PCOS patients 
compared with control. This study provided new evidence for understanding the pathogenesis of PCOS.
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Background
Polycystic ovarian syndrome (PCOS) is a very common 
female endocrine disorder among infertile female individ-
uals and affects approximately 5–10% of women of repro-
ductive age worldwide. Women with PCOS frequently 
present with reproductive dysfunction, and PCOS is 
the main cause of infertility due to dysfunctional folli-
cular maturation and ovulation, distinctive multicystic 
ovaries and dysregulation of reproductive hormones 
including luteinizing hormone (LH) hypersecretion and 
hyperandrogenism. Besides the reproductive abnormali-
ties, PCOS women also exhibit non-reproductive meta-
bolic abnormalities such as obesity, metabolic syndrome, 
hyperinsulinemia, insulin resistance, dyslipidemia and 
type 2 diabetes [1–4]. Despite its prevalence, the etiology 
of PCOS remains unclear.
Although it is difficult to define the exact pathogenesis 
of anovulation in PCOS, many possible mechanisms have 
been postulated. Hypersecretion of LH, hyperandroge-
naemia and hyperinsulinaemia have all been investigated 
as possible causes of PCOS. It has been showed that alter-
ation of many factors might directly or indirectly impair 
the competence of maturating oocytes through endo-
crine and local paracrine/autocrine actions, resulting in 
a lower pregnancy rate in patients with PCOS [5–8]. It 
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was likely that these factors were interlinked together and 
might result in disordered ovarian function in PCOS [9].
In recent years, miRNAs have emerged as critical regu-
lators of gene expression in mammals. The non-coding 
RNA molecules serve as a fundamental role in the reg-
ulation of gene expression, and it is estimated that the 
expression of 30% of genes are the potential target of 
miRNAs regulatory function [10]. By using Dicer1 con-
ditional knockout (cKO) mouse, people showed that 
Dicer1, the ribonuclease III for synthesis of mature func-
tional miRNAs, played important roles in follicular cell 
development through the differential regulation of gene 
expression [11]. Recently, it was reported that miR-29a, 
miR-30d and miR-224 were involved in folliculogenesis 
in mouse [12].
Folliculogenesis in anovulatory women with PCOS is 
characterized by failure of dominance and the ovary has 
multiple arrested small follicles. The ovarian follicular 
microenvironment and maternal signals were respon-
sible for oocyte growth, development and the gradual 
acquisition of oocyte developmental competence [13]. 
The cumulus cells are a subset of granulose cells which 
maintain an intimate connection with the oocyte and are 
responsible for providing several tropic and metabolic 
factors to the pre-ovulatory oocyte. It has been found 
that cumulus cells played an important roles in promot-
ing normal cytoplasmic maturation of oocytes necessary 
for pronuclear formation and subsequent development 
capability [14].
Because cumulus cells can obtained easily before 
intra-cytoplasmic injection (ICSI) procedure or before 
insemination for classical in  vitro fertilization (IVF), 
several groups used microarray technologies, RT-PCR 
and quantitative RT-PCR analyses to link the cumulus 
cells gene expression profile with oocyte quality and/
or embryo competence and/or pregnancy outcome [5, 
15–17]. In recent years, there were some studies about 
the transcriptional profiles of human cumulus cells 
from PCOS patients [18–21]. Although a large number 
of genes have been shown to be associated with PCOS, 
the underlying post-transcriptional regulation of gene 
expression remains poorly understood [18, 22–25], 
especially the role of miRNAs in human cumulus cells 
[26].
Several features of miRNAs, including their stabil-
ity and tissue specificity, make them suitable for their 
detection and relative quantification in a variety of tis-
sues. Genomic scale profiling has been routinely applied 
in miRNAs research. Deep sequencing, which utilizes 
the latest massively parallel sequencing, has provided 
an alternative way to obtain miRNAs profiles at unprec-
edented sensitivity [27, 28]. This study was aimed at the 
identification and quantification of miRNAs in PCOS 




Samples were collected after the patients gave their writ-
ten informed consent and the study was approved by the 
Ethical Committee of the The Obstetrics and Gynecology 
Hospital of Fudan University (Shanghai Red House Ob 
and Gyn Hospital) and carried out in compliance with 
the Helsinki Declaration.
The diagnosis of PCOS was based on the Rotterdam 
revised criteria after ruling out secondary causes [29]. 
Between July 2012 and December 2012, a total of 20 par-
ticipants (10 PCOS and 10 controls) were enrolled in the 
study. All patients had no history of drugs affecting glu-
cose and lipid metabolism, and inclusion criteria for all of 
the subjects included the following: a basal follicle stimu-
lating hormone (FSH) level of <10 IU/L; age <35 years; a 
body mass index (BMI) <25  kg/m2 (Table  1). We meas-
ured the level of FSH and LH on day 3 of menstrual cycle 
before the ovarian stimulation. Exclusion criteria in con-
trol included any known medical conditions or diseases. 
Care was taken to exclude hyperandrogenism and chro-
mic anovulation.
All the participants included in the study were women 
undergoing IVF with ICSI at Shanghai Jiai Genetics and 
IVF Institute, and all the ICSI cycles included were con-
ducted according to the long mid-luteal GnRH agonist 
(Ferring Pharmaceuticals, Switzerland) protocol. All 
patients were undergoing ICSI due to male factor infer-
tility. Controlled ovarian stimulation was conducted 
with recombinant human FSH (Gonal-f, Merck Serono). 
Oocytes injection and embryos culture were performed 
as described previously [30]. For oocyte retrieval, all 
patients underwent ovarian puncture of follicles >15 mm 
in diameter. Only the cumulus-oocyte complexes with 
mature oocytes (MII) were included in this study.
Table 1 Characteristic of PCOS and control participants
Characteristic Control (n = 10) PCOS (n = 10)
Age (years) 29.4 ± 3.0 27.4 ± 2.6
BMI (kg/m2) 23.5 ± 3.2 22.0 ± 3.5
FSH (mIU/ml) 7.5 ± 2.5 5.2 ± 1.6
LH (mIU/mL) 4.3 ± 1.6 7.3 ± 1.7
LH/FSH 0.57 ± 0.2 1.4 ± 0.6
Oocytes obtained 8.8 ± 3.0 18.8 ± 5.3
No of MII oocytes 6.6 ± 2.0 15.6 ± 7.7
2PN 5.8 ± 1.4 14.6 ± 6.3
No of transferable embryos 4.2 ± 2.0 8.8 ± 4.9
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Cumulus cell collection
The cumulus cells were collected as previously described 
[31]. Briefly, oocyte retrieval was performed transvaginally 
35  h after the triggering of ovulation. Cumulus-oocyte 
complexes were collected in MOPS medium (Vitrolife, 
Sweden) and the cumulus cell were mechanically stripped 
from oocyte after brief exposure to hyaluronidase (Vitro-
life, Sweden) under stereomicroscopy. The cumulus cells 
were washed three times with culture medium and frozen 
individually prior to total RNA extraction.
Small RNA deep sequencing and data analyses
We randomly selected 5 PCOS and 5 control samples used 
for deep sequencing. Total RNA from cumulus cells of 
each sample was extracted using TRIzol reagent accord-
ing to the manufacturer’s protocol (Invitrogen, USA), 
respectively. The concentration of the RNA was meas-
ured by NanoDrop and the RNA integrity was checked 
on Bioanalyzer2100 (Agilent, USA). 200 ng of total RNA 
was used for preparing small RNA libraries for deep 
sequencing according to the manufacturer’s instructions 
(Illumina, USA). The cDNA libraries were sequenced on 
Illumina HiSeq 2000 instrument with 50-base pair sin-
gle reads. Raw sequencing data was mapped to human 
miRNA database (miRBase v21) using Bowtie2.
The Mann–Whitney test was performed to discover dif-
ferentially expressed miRNAs between PCOS and control 
samples. The miRNAs used for biological functional anal-
yses were significantly differentially expressed (p  <  0.05 
and fold change >2) in the cumulus cells of PCOS.
Unsupervised hierarchical clustering analysis was 
conducted. We perform cluster analysis of gene expres-
sion patterns with “gplots”, which is a package for R. 
(http://CRAN.R-project.org/package=gplots) software. 
We used the Euclidean distance measure and the aver-
age linkage clustering algorithm. The branching pattern 
was illustrated in a dendrogram in which the similarity 
between the miRNAs expression profiles could be visu-
ally assessed.
To determine miRNAs regulation pathway, we searched 
for putative miRNAs that are able to target based on 
commonly cited prediction programs such as miRanda 
[32]. GO term was assigned to each target gene accord-
ing to Gene Ontology, and then ultra-geometric test was 
used to find out enrich term in this analysis. In the same 
way, pathway id was assigned to every gene by KEGG 
database, then ultra-geometric test was used to find out 
enrichment pathway in our analysis.
Real‑time PCR
After random selection 5 PCOS and 5 control samples 
used for deep sequencing, the remaining samples were 
used for real-time PCR. Total RNAs of 10 samples were 
extracted using TRIzol reagent (invitrogen), respectively. 
RT-qPCR was carried out using the miRCURY LNA™ 
Universal RT miRNAs PCR system (Exiqon, MA, USA) 
according to the manufacturer’s description, and ana-
lysed using an ABI 7900 HT (Applied Biosystems, Fos-
ter, CA, USA). All miRNAs Assay primers used in this 
study were purchased commercially (Exiqon, MA, USA). 
Primer efficiencies were determined by standard curve. 
Relative miRNAs expression was calculated by efficiency-
corrected ΔΔCt method, normalized to the endogenous 
control U6 snRNA. Each sample in each group was meas-
ured in triplicate and the experiment was repeated for at 
least three times.
Statistical analysis
All values are presented as mean  ±  SEM. Statistical 
comparisons among groups were analyzed by one-way 
ANOVA followed by student’s t test using SPSS software 
package (version 10.0.1, SPSS Inc., Chicago, IL, USA). A 
value of p < 0.05 was considered significant.
Results
Differentially expressed miRNAs profiles of cumulus cells 
isolated from PCOS and control
By deep sequencing, we have obtained a total of 
29,955,439 sequences reads, and 5,448,483 sequences 
reads of 648 kinds of miRNAs, which perfectly matched 
human miRNAs database (miRBase v21). Then the 
Mann–Whitney test was performed to discover differ-
entially expressed miRNAs between PCOS and control 
group. We focused on miRNAs meeting our designated 
criteria: p < 0.05 and fold change ≥2. A total of 17 miR-
NAs were identified: 10 miRNAs upregulated and 7 miR-
NAs down-regulated on PCOS compared with control 
(Table 2).
To gain a systematic comparison between the two 
groups of miRNAs expression profiles, unsupervised 
hierarchical clustering analysis was conducted. The unsu-
pervised hierarchical clustering generated a tree with a 
clear distinction of samples in two main groups, repre-
sented by PCOS and control (Figure 1).
To validate the reliability of the deep sequencing 
data, we selected 6 miRNAs, 4 up-regulated miRNAs 
(hsa-miR-513-3p, hsa-miR-508-3p, hsa-miR-513b and 
hsa-miR-144) and 2 down-regulated miRNAs (hsa-miR-
455-3p and hsa-miR-615-3p) in PCOS, confirmed that 
their expression pattern using qPCR. The results showed 
that the expression pattern of all 6 miRNAs analyzed by 
qPCR were in concordance with the deep sequencing 
data, which indicated that our deep sequencing data were 
reliable (Figure 2).
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Identification and functional analysis of miRNA‑predicted 
targets
The predicted target mRNAs of the 17 differentially 
expressed miRNAs were identified in silico. Using a com-
putational miRNAs target gene prediction (miRanda), we 
identified 3781 putative differentially expressed mRNAs. 
The functions of the predicted miRNAs target gene and 
the molecular pathways they potentially constitute were 
assessed using GO and KEGG analysis. The predicted 
targets were significantly enriched for several biological 
functions known to be involved in oocyte development, 
mitogen activated protein kinase (MAPK) signaling path-
way, Wnt signaling pathway, regulation of actin cytoskel-
eton, steroid hormone biosynthesis, oocyte meiosis, gap 
junction and GnRH signaling pathway (Table  3). The 
Wnt signaling network enriched for miRNAs targets was 
shown in Figure  3. We chose to present this particular 
pathway since this pathway converges with other path-
ways that biologically relevant to oocyte development, 
such as cell cycle, adherens junction and transforming 
growth factor beta (TGF beta).
Discussion
In this study, cumulus cells from PCOS and control were 
collected before ICSI, and miRNAs expression profiles 
were analyzed using deep sequencing technology. We 
detected 648 known miRNAs in cumulus cells. Com-
paring miRNAs expression profiles between PCOS and 
control group, we identified that there were 17 miRNAs 
differentially expressed. To confirm the reliability of the 
deep sequencing data, we selected 6 miRNAs to examine 
their expression pattern in cumulus cells of PCOS and 
controls by using qPCR. The results of qPCR were con-
sistent with deep sequencing data. Unsupervised hierar-
chical clustering analysis showed a separation between 
PCOS and control group. Investigating the role of miR-
NAs in PCOS, Xu et  al. found that a total of 59 known 
miRNAs were differentially expressed in PCOS cumulus 
Table 2 Differentially expressed miRNAs in PCOS
miRNA name PCOS Control Folds change P value
hsa-miR-513a-3p 49 9 5.6 0.009
hsa-miR-508-3p 181 69 2.6 0.009
hsa-miR-513b 20 6 3.4 0.009
hsa-miR-514 288 84 3.4 0.009
hsa-miR-509-5p 108 33 3.3 0.009
hsa-miR-513c 13 4 3.5 0.011
hsa-miR-151-3p 135 216 0.6 0.028
hsa-miR-144 45 7 6.2 0.028
hsa-miR-510 36 16 2.2 0.028
hsa-miR-720 32 88 0.4 0.028
hsa-miR-615-3p 17 58 0.3 0.028
hsa-miR-509-3p 551 255 2.2 0.028
hsa-miR-127-3p 361 1,045 0.3 0.028
hsa-miR-455-3p 11 25 0.4 0.036
hsa-miR-342-3p 85 172 0.5 0.036
hsa-miR-654-3p 20 40 0.5 0.046
hsa-miR-508-5p 38 20 1.9 0.047
Figure 1 Unsupervised hierarchical clustering of deep sequencing data. Heatmap of miRNA expression data after hierarchical clustering. The 
Euclidean distance measure and the average linkage clustering algorithm were used. The branching pattern was illustrated in a dendrogram.
Page 5 of 9Liu et al. J Transl Med  (2015) 13:238 
granulosa cells, including 21 miRNAs increase and 38 
miRNAs decrease [33]. Comparing our results with that 
of the previous results [33], we found that there was no 
overlap of the differentially expressed miRNAs at all. 
The inconsistency of results obtained from our lab with 
the results obtained from Xu’s might reinforce the find-
ing that PCOS is a multi-factorial and heterogeneous 
syndrome. So, identification of differentially expressed 
miRNAs in a larger scale of patients may help to improve 
understanding of the underlying molecular mechanism 
of PCOS.
Since each miRNA has been predicted to have a broad 
range of target mRNA based on the degree of sequence 
homology. We would like to identify their predicted tar-
gets as well as the molecular networks and the biological 
functions they may affect. To fully characterize these dif-
ferently expressed miRNAs, gene ontology analysis was 
performed on the predicted gene targets for the 17 differ-
entially regulated miRNAs, which putatively regulate the 
expression of 3781 genes. It was revealed that these genes 
associated with diverse important signaling pathways 
such as MAPK signaling pathway, Wnt signaling path-
way, insulin signaling pathway and GnRH signaling path-
way. Our results was supported by the finding that the 
genes of the Wnt- and MAPK-signaling pathways were 
generally down-regulated in the PCOS [19]. Importantly, 
the predicted gene targets were associated with oocyte 
meiosis and progesterone-mediated oocyte maturation. 
Also, the gene ontology analysis results predicted that the 
differentially expressed miRNAs might involved in Type 
I diabetes mellitus, Type II diabetes mellitus, starch and 
sucrose metabolism and steroid biosynthesis (Table  3). 
So, our results suggested that miRNAs might play impor-
tant roles in PCOS, and elucidating the roles of miRNAs 
in PCOS should be the subject of future investigations.
The changes in the expression of even a single miRNA 
could have a detrimental impact on the outcome of 
diverse cellular activities regulated by the product of 
these genes, such as oocyte development and maturation. 
Because these dysregulated genes might link to diverse 
pathways such as lipid metabolism, and insulin signal-
ing and oocyte maturation, which was proven related to 
PCOS, we speculated that differently expressed miRNAs 
might be involved in follicular growth arrest and meta-
bolic disorders associated with PCOS.
Several studies on miRNAs expression have been 
done on the different ovarian components of human, 
such as granulose cells [34] and follicular fluid [35, 
36], but the possible role of miRNAs within the patho-
physiology of PCOS has only been sparsely investi-
gated [12, 34, 35, 37–39]. Little was known regarding 
the involvement of miRNAs during follicular develop-
ment and in PCOS. In PCOS, an accelerated early fol-
licular growth leaded to an excess of small follicles [40]. 
Figure 2 Differential expression of six miRNAs in cumulus cells of PCOS patients and control.
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Different factors have been reported to participate in 
the growth of follicles and the maturation of oocyte 
[41]. The TGF beta superfamily, which includes inhib-
ins, activins, growth differentiation factors (GDFs) and 
bone morphogenetic protein (BMPs), played a central 
role in many processes that governed follicle devel-
opment, oocyte maturation and competence [42]. It 
has been reported that in PCOS cumulus cells, 65% 
of genes related to the TGF beta signalling pathways 
were down-regulated, including several members of 
the TGF beta superfamily, type II TGF beta receptors 
and their targets SMAD1/5, as well as the TGF beta 
receptor III (TGFBR3) [18]. According to our heatmap, 
hsa-miR-514, hsa-miR-144 and hsa-miR-513a-3p dif-
ferentially expressed in PCOS patients. When classi-
fied into biological function, these three miRNAs were 
enriched for several pathways known to be crucial in 
the process of oocyte development and maturation 
such as TGF-beta signaling pathway, MAPK signal-
ing pathway, estrogen signaling pathway and oocyte 
maturation, etc. The functional annotation of differen-
tially expressed miRNAs in our study was in agreement 
with other studies that have found that defects in the 
TGF-beta and estrogen receptors signalling cascades 
may contribute to the reduced oocyte developmental 
competence in PCOS [18, 26]. Also, miR-513a-3p and 
luteinizing hormone/chorionic gonadotropin recep-
tor (LHCGR) were both expressed in human ovarian 
granulosa cells. The LHCGR is a G protein-coupled 
receptor (GPCR) that plays a central role in ovarian fol-
licular maturation, ovulation and maintenance of cor-
pus luteum and pregnancy. LHCGR was a predicted 
target of miR-513a-3p, and downregulation of LHCGR 
expression by miR-513a-3p has been observed [43]. 
Therefore, miR-513a-3p may be involved in follicular 
maturation in response to abnormal hormone microen-
vironment in PCOS follicles.
Oocyte competence depends on the quality of the fol-
licular microenvironment and the presence of adequate 
bidirectional cumulus cell-oocyte signaling is primordial 
for both oocyte and cumulus cells competence acqui-
sition [20, 44]. Interaction between cumulus cells and 
oocytes involves both gap junctions and paracrine sign-
aling factors. Gap junctions allow transfer of small mol-
ecules and facilitate exchange of glucose metabolites 
and ions between the cumulus cells and oocytes [45]. 
Our results found that hsa-miR-508-5p/3p, when clas-
sified into biological function, were enriched for several 
pathways known to be crucial in cell communication, 
including ECM-receptor interaction, focal adhesion, 
tight junction and gap junction. Our miRNAs biological 
function prediction results implied that miRNAs might 
involved in cell communication system during oocyte 
competence development, but the molecular mechanism 
still need be identified.
Conclusions
In summary, we identified differentially expressed miR-
NAs in PCOS cumulus cells. Bioinformatics analysis gene 
targets of these differentially expressed miRNAs provided 
additional information on the molecular events that lead 
to PCOS pathogenesis. Many of the miRNA-regulated 
molecular networks and biological processes identified 
here corroborated what was previously suggested in the 
Table 3 Annotation results from GO analysis
P value Ratio
Pathways
 MAPK signaling pathway 1.21E−60 160 287
 Wnt signaling pathway 4.87E−49 104 159
 Insulin signaling pathway 1.93E−20 90 230
 Notch signaling pathway 1.09E−18 36 53
 p53 signaling pathway 3.02E−18 46 83
 GnRH signaling pathway 3.66E−14 60 153
 Hedgehog signaling pathway 1.03E−13 35 65
Networks
 Regulation of actin cytoskeleton 1.91E−30 125 303
 Focal adhesion 1.34E−26 124 324
 Cell cycle 8.90E−23 87 204
 Oocyte meiosis 1.55E−19 70 159
 ECM-receptor interaction 3.62E−19 57 115
 Gap junction 3.09E−16 61 144
 Pancreatic secretion 2.98E−12 61 171
 Progesterone-mediated oocyte maturation 1.66E−10 52 147
Diseases
 Pancreatic cancer 8.85E−14 42 88
 Type I diabetes mellitus 1.28E−11 30 57
 Endometrial cancer 1.56E−09 31 70
 Type II diabetes mellitus 4.05E−08 24 52
 Maturity onset diabetes of the young 8.60E−08 17 30
Metabolisms
 Glycosaminoglycan biosynthesis-heparan 
sulfate
6.85E−17 23 26
 N-Glycan biosynthesis 5.31E−16 32 49
 Starch and sucrose metabolism 4.34E−13 33 61
 Amino sugar and nucleotide sugar metabolism 9.32E−09 24 49
 Fructose and mannose metabolism 2.38E−08 22 44
 Glycine, serine and threonine metabolism 4.03E−08 22 45
 Galactose metabolism 6.36E−07 16 30
 Steroid biosynthesis 9.98E−05 10 19
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literature about oocyte competence defects. The molecu-
lar pathways presented here constituted a comprehensive 
resource on which to base future investigations into the 
role of specific miRNAs in PCOS.
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